200 related articles for article (PubMed ID: 10511102)
41. The route of administration drastically affects ivermectin activity against small strongyles in horses.
Saumell C; Lifschitz A; Baroni R; Fusé L; Bistoletti M; Sagües F; Bruno S; Alvarez G; Lanusse C; Alvarez L
Vet Parasitol; 2017 Mar; 236():62-67. PubMed ID: 28288767
[TBL] [Abstract][Full Text] [Related]
42. Comparative plasma and milk dispositions, faecal excretion and efficacy of per os ivermectin and pour-on eprinomectin in horses.
Gokbulut C; Ozuicli M; Aksit D; Aksoz E; Korkut O; Yalcinkaya M; Cirak VY
J Vet Pharmacol Ther; 2016 Dec; 39(6):584-591. PubMed ID: 27016093
[TBL] [Abstract][Full Text] [Related]
43. The pharmacokinetics of orally administered ivermectin in African elephants (Loxodonta africana): implications for parasite elimination.
Gandolf AR; Lifschitz A; Stadler C; Watson B; Galvanek L; Ballent M; Lanusse C
J Zoo Wildl Med; 2009 Mar; 40(1):107-12. PubMed ID: 19368248
[TBL] [Abstract][Full Text] [Related]
44. The effects of different ages and dosages on the plasma disposition and hair concentration profile of ivermectin following pour-on administration in goats.
Gokbulut C; Cirak VY; Senlik B; Aksit D; McKellar QA
J Vet Pharmacol Ther; 2011 Feb; 34(1):70-5. PubMed ID: 21219347
[TBL] [Abstract][Full Text] [Related]
45. Comparative plasma disposition, bioavailability and efficacy of ivermectin following oral and pour-on administrations in horses.
Gokbulut C; Cirak VY; Senlik B; Aksit D; Durmaz M; McKellar QA
Vet Parasitol; 2010 May; 170(1-2):120-6. PubMed ID: 20181429
[TBL] [Abstract][Full Text] [Related]
46. Plasma dispositions of ivermectin, doramectin and moxidectin following subcutaneous administration in rabbits.
Gokbulut C; Biligili A; Kart A; Turgut C
Lab Anim; 2010 Apr; 44(2):138-42. PubMed ID: 19959569
[TBL] [Abstract][Full Text] [Related]
47. Comparison of pharmacokinetic profiles of doramectin and ivermectin pour-on formulations in cattle.
Gayrard V; Alvinerie M; Toutain PL
Vet Parasitol; 1999 Feb; 81(1):47-55. PubMed ID: 9950328
[TBL] [Abstract][Full Text] [Related]
48. Field trial assessment of ivermectin pharmacokinetics and efficacy against susceptible and resistant nematode populations in cattle.
Canton C; Canton L; Domínguez MP; Moreno L; Lanusse C; Alvarez L; Ceballos L
Vet Parasitol; 2018 May; 256():43-49. PubMed ID: 29887029
[TBL] [Abstract][Full Text] [Related]
49. Comparative pharmacokinetics of ivermectin after its subcutaneous administration in healthy sheep and sheep infected with mange.
Echeverría J; Mestorino N; Errecalde JO
J Vet Pharmacol Ther; 2002 Apr; 25(2):159-60. PubMed ID: 12000537
[No Abstract] [Full Text] [Related]
50. Assessment of a liposomal formulation of ivermectin in rabbit after a single subcutaneous administration.
Bassissi F; Lespine A; Alvinerie M
Parasitol Res; 2006 Feb; 98(3):244-9. PubMed ID: 16341879
[TBL] [Abstract][Full Text] [Related]
51. Ivermectin pharmacokinetics in lactating sheep.
Cerkvenik V; Grabnar I; Skubic V; Doganoc DZ; Beek WM; Keukens HJ; Drobnic Kosorok M; Pogacnik M
Vet Parasitol; 2002 Mar; 104(2):175-85. PubMed ID: 11809336
[TBL] [Abstract][Full Text] [Related]
52. The comparative serum disposition kinetics of subcutaneous administration of doramectin, ivermectin and moxidectin in the Australian Merino sheep.
Barber S; Bowles V; Lespine A; Alvinerie M
J Vet Pharmacol Ther; 2003 Oct; 26(5):343-8. PubMed ID: 14633186
[TBL] [Abstract][Full Text] [Related]
53. Treatment and control of bovine sarcoptic and psoroptic mange infestation with ivermectin long-acting injectable (IVOMEC(®) GOLD).
Hamel D; Joachim A; Löwenstein M; Pfister K; Silaghi C; Visser M; Winter R; Yoon S; Cramer L; Rehbein S
Parasitol Res; 2015 Feb; 114(2):535-42. PubMed ID: 25399813
[TBL] [Abstract][Full Text] [Related]
54. Effect of parasitism on the pharmacokinetic disposition of ivermectin in lambs.
Pérez R; Palma C; Cabezas I; Araneda M; Rubilar L; Alvinerie M
J Vet Med A Physiol Pathol Clin Med; 2006 Feb; 53(1):43-8. PubMed ID: 16411909
[TBL] [Abstract][Full Text] [Related]
55. Loperamide modifies the tissue disposition kinetics of ivermectin in rats.
Lifschitz AL; Virkel GL; Sallovitz JM; Pis A; Imperiale FA; Lanusse CE
J Pharm Pharmacol; 2004 Jan; 56(1):61-7. PubMed ID: 14980002
[TBL] [Abstract][Full Text] [Related]
56. Comparative assessment of different ivermectin and doramectin formulations for mange control in grazing steers.
Canton C; Muchiut S; Dominguez MP; Lanusse C; Alvarez LI; Lifschitz A
Vet Parasitol; 2023 Apr; 316():109891. PubMed ID: 36780819
[TBL] [Abstract][Full Text] [Related]
57. Ivermectin environmental impact: Excretion profile in sheep and phytotoxic effect in Sinapis alba.
Vokřál I; Michaela Š; Radka P; Jiří L; Lukáš P; Dominika S; Kateřina L; Barbora S; Lenka S
Ecotoxicol Environ Saf; 2019 Mar; 169():944-949. PubMed ID: 30597795
[TBL] [Abstract][Full Text] [Related]
58. Resistance of Cooperia to ivermectin treatments in grazing cattle of the Humid Pampa, Argentina.
Fiel CA; Saumell CA; Steffan PE; Rodriguez EM
Vet Parasitol; 2001 Jun; 97(3):211-7. PubMed ID: 11390073
[TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetics of a novel closantel/ivermectin injection in cattle.
Cromie L; Ferry M; Couper A; Fields C; Taylor SM
J Vet Pharmacol Ther; 2006 Jun; 29(3):205-11. PubMed ID: 16669865
[TBL] [Abstract][Full Text] [Related]
60. Ivermectin in senegalese peulh sheep: influence of sex on plasma disposition.
Ndong TB; Kane Y; Diouf EH; Alvinerie M
Vet Res Commun; 2007 Aug; 31(6):739-47. PubMed ID: 17260181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
